↓ Skip to main content

A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout

Overview of attention for article published in Annals of the Rheumatic Diseases, March 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news
2 news outlets
policy
2 policy sources
twitter
11 X users
reddit
1 Redditor
guideline
1 clinical guideline source
podcasts
1 podcast

Readers on

mendeley
98 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout
Published in
Annals of the Rheumatic Diseases, March 2017
DOI 10.1136/annrheumdis-2016-210872
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 98 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 13 13%
Student > Master 10 10%
Student > Postgraduate 10 10%
Student > Ph. D. Student 9 9%
Other 7 7%
Other 24 24%
Unknown 25 26%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 42 43%
Pharmacology, Toxicology and Pharmaceutical Science 13 13%
Nursing and Health Professions 7 7%
Environmental Science 3 3%
Social Sciences 2 2%
Other 7 7%
Unknown 24 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 37. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 June 2026.
All research outputs
#1,387,546
of 34,297,219 outputs
Outputs from Annals of the Rheumatic Diseases
#800
of 10,573 outputs
Outputs of similar age
#21,934
of 369,378 outputs
Outputs of similar age from Annals of the Rheumatic Diseases
#10
of 57 outputs
Altmetric has tracked 34,297,219 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,573 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.5. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 369,378 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.